Flashlight

DOI: 10.4244/EIJ-D-25-01107

Feasibility and challenges of the UNICORN technique in native aortic valve transcatheter aortic valve implantation

Jean-Benoît Veillette1,2, MD; Anthony Poulin1,2, MD; Siddhartha Mengi1,2, MD; Erwan Salaun1,2, MD; Jean-Michel Paradis1,2, MD

An 84-year-old female with severe native aortic stenosis was admitted for transcatheter aortic valve implantation (TAVI). Following a multidisciplinary Heart Team discussion, she was deemed unsuitable for cardiac surgery due to frailty, elevated surgical risk (Society of Thoracic Surgeons score of 6.2%), and patient preference. Computed tomography (CT) demonstrated a high risk of left coronary obstruction (Figure 1).

Several coronary protection techniques have previously been described, including chimney stenting, BASILICA (bioprosthetic aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction), UNICORN (undermining iatrogenic coronary obstruction with radiofrequency needle), and LLAMACORN (leaflet laceration with balloon-mediated annihilation to prevent coronary obstruction with radiofrequency needle). Chimney stenting involves deploying a stent that protrudes into the aorta and is associated with risks of stent deformation and thrombosis, and may compromise future coronary access.1 BASILICA, the first leaflet modification technique to be described, has demonstrated efficacy in reducing the risk of coronary occlusion, although unpredictable leaflet splay may occur, thus resulting in coronary occlusion, especially in cases of high coronary eccentricity.12 UNICORN is an alternative leaflet modification strategy, consisting of...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 22 Number 11
Jun 1, 2026
Volume 22 Number 11
View full issue


Key metrics

Suggested by Cory

Flashlight

10.4244/EIJ-D-25-00985 Mar 16, 2026
Risk of leaflet avulsion after UNICORN leaflet modification
Khokhar A et al

Image – Interventional flashlight

10.4244/EIJ-D-22-00344 Aug 5, 2022
First dedicated transcatheter leaflet splitting device: the ShortCut device
Tchétché D et al
free

Editorial

10.4244/EIJ-E-23-00026 Aug 7, 2023
Orthotopic stenting after BASILICA – an indicator of procedural success
Rogers T and Bruce C
free

Image – Interventional flashlight

10.4244/EIJ-D-22-00149 Nov 18, 2022
Coronary access techniques following ACURATE neo2 implantation in surgical bioprosthesis
Khokhar A et al
free

Clinical research

10.4244/EIJ-D-22-00960 Aug 7, 2023
Procedural and one-year outcomes of the BASILICA technique in Europe: the multicentre EURO-BASILICA registry
Abdel-Wahab M et al
free
Trending articles
334.8

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved